279 related articles for article (PubMed ID: 19675671)
1. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.
Smolders J; Thewissen M; Peelen E; Menheere P; Tervaert JW; Damoiseaux J; Hupperts R
PLoS One; 2009 Aug; 4(8):e6635. PubMed ID: 19675671
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis.
Smolders J; Menheere P; Thewissen M; Peelen E; Tervaert JW; Hupperts R; Damoiseaux J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):243-6. PubMed ID: 20211254
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
[TBL] [Abstract][Full Text] [Related]
4. Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.
Smolders J; Peelen E; Thewissen M; Cohen Tervaert JW; Menheere P; Hupperts R; Damoiseaux J
PLoS One; 2010 Dec; 5(12):e15235. PubMed ID: 21179201
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects of Vitamin D in multiple sclerosis.
Correale J; Ysrraelit MC; Gaitán MI
Brain; 2009 May; 132(Pt 5):1146-60. PubMed ID: 19321461
[TBL] [Abstract][Full Text] [Related]
6. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
7. Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.
Smolders J; Peelen E; Thewissen M; Menheere P; Damoiseaux J; Hupperts R
Mult Scler; 2014 Apr; 20(4):433-7. PubMed ID: 23959712
[TBL] [Abstract][Full Text] [Related]
8. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.
Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P
Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326
[TBL] [Abstract][Full Text] [Related]
9. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
Smolders J; Menheere P; Kessels A; Damoiseaux J; Hupperts R
Mult Scler; 2008 Nov; 14(9):1220-4. PubMed ID: 18653736
[TBL] [Abstract][Full Text] [Related]
10. Immune regulatory effects of high dose vitamin D
Muris AH; Smolders J; Rolf L; Thewissen M; Hupperts R; Damoiseaux J;
J Neuroimmunol; 2016 Nov; 300():47-56. PubMed ID: 27806875
[TBL] [Abstract][Full Text] [Related]
11. A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
Muris AH; Rolf L; Broen K; Hupperts R; Damoiseaux J; Smolders J
J Steroid Biochem Mol Biol; 2016 Nov; 164():254-257. PubMed ID: 26598277
[TBL] [Abstract][Full Text] [Related]
12. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
[TBL] [Abstract][Full Text] [Related]
14. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
Brola W; Sobolewski P; Szczuchniak W; Góral A; Fudala M; Przybylski W; Opara J
Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420
[TBL] [Abstract][Full Text] [Related]
15. Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.
Grau-López L; Granada ML; Raïch-Regué D; Naranjo-Gómez M; Borràs-Serres FE; Martínez-Cáceres E; Ramo-Tello C
BMC Neurol; 2012 Sep; 12():103. PubMed ID: 23006125
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis.
Azimi M; Ghabaee M; Moghadasi AN; Noorbakhsh F; Izad M
Immunol Res; 2018 Aug; 66(4):513-520. PubMed ID: 29882035
[TBL] [Abstract][Full Text] [Related]
17. Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.
Peelen E; Damoiseaux J; Smolders J; Knippenberg S; Menheere P; Tervaert JW; Hupperts R; Thewissen M
J Neuroimmunol; 2011 Dec; 240-241():97-103. PubMed ID: 22035960
[TBL] [Abstract][Full Text] [Related]
18. Physical activity in multiple sclerosis: a comparative study of vitamin D, brain-derived neurotrophic factor and regulatory T cell populations.
Waschbisch A; Wenny I; Tallner A; Schwab S; Pfeifer K; Mäurer M
Eur Neurol; 2012; 68(2):122-8. PubMed ID: 22832849
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis.
Royal W; Mia Y; Li H; Naunton K
J Neuroimmunol; 2009 Aug; 213(1-2):135-41. PubMed ID: 19539379
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the cord vitamin D levels and regulatory T cells in newborn infants.
Güven A; Ecevit A; Sözer O; Tarcan A; Tarcan A; Ozbek N
Eur J Pediatr; 2012 Aug; 171(8):1161-6. PubMed ID: 22383070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
